SCHEMBL2496902

SCHEMBL2496902

N#Cc1ccc2c(c1)C(O)(c1cccc3c1OCO3)C(=O)N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.40
RAF1 P04049 1/20 0.36
BRAF P15056 1/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
F2 P00734 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MTOR P42345 1/20 0.35
RICTOR Q6R327 1/20 0.35
RPTOR Q8N122 1/20 0.35
MAPKAP1 Q9BPZ7 1/20 0.35
MLST8 Q9BVC4 1/20 0.35
BRD4 O60885 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GSK3B P49841 1/20 0.34
MAPT P10636 1/20 0.33
DRD2 P14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2496712 0.83 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2KMT2AMEN1USP2
SCHEMBL2492740 0.83 IDO1 (0.41) PGRALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL2492868 0.83 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KMT2AMEN1USP2
SCHEMBL2496973 0.83 L3MBTL1 (0.52) ALDH1A1SMN1; SMN2KMT2AMEN1USP2
SCHEMBL2492745 0.83 ALDH1A1 (0.38) BRAFALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL2501554 0.79 ALPL (0.47) PGRRAF1BRAFALDH1A1SMN1; SMN2
SCHEMBL2497599 0.78 MAOB (0.45) ALDH1A1SMN1; SMN2KMT2AMEN1USP2
SCHEMBL2498220 0.76 MDM2 (0.38) RAF1KMT2AMEN1MTORRICTOR
SCHEMBL2496469 0.74 GSK3B (0.38) ALDH1A1KMT2AMEN1MTORRICTOR
SCHEMBL2493428 0.73 BRD4 (0.38) PGRALDH1A1MTORRICTORRPTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 PGR 413/4885RAF1 1957/4885BRAF 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.